Table of Content

Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Hereditary Angioedema Drug Market Status and Forecast (2016-2027)
1.3.2 Global Hereditary Angioedema Drug Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Hereditary Angioedema Drug Supply by Company
2.1 Global Hereditary Angioedema Drug Sales Volume by Company
2.2 Global Hereditary Angioedema Drug Sales Value by Company
2.3 Global Hereditary Angioedema Drug Price by Company
2.4 Hereditary Angioedema Drug Production Location and Sales Area of Main Manufacturers
2.5 Trend of Concentration Rate
3 Global and Regional Hereditary Angioedema Drug Market Status by Type
3.1 Hereditary Angioedema Drug Type Introduction
3.1.1 C1 Esterase Inhibitor
3.1.2 Kallikrein Inhibitor
3.1.3 Selective Bradykinin B2 Receptor Antagonist
3.2 Global Hereditary Angioedema Drug Market by Type
3.2.1 Global Hereditary Angioedema Drug Sales Volume by Type (2016-2021)
3.2.2 Global Hereditary Angioedema Drug Sales Value by Type (2016-2021)
3.2.3 Global Hereditary Angioedema Drug Price by Type (2016-2021)
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Hereditary Angioedema Drug Market Status by Application
4.1 Hereditary Angioedema Drug Segment by Application
4.1.1 Retail Pharmacies
4.1.2 Hospital Pharmacies
4.1.3 Online Pharmacies
4.2 Global Hereditary Angioedema Drug Market by Application
4.2.1 Global Hereditary Angioedema Drug Sales Volume by Application (2016-2021)
4.2.2 Global Hereditary Angioedema Drug Sales Value by Application (2016-2021)
4.2.3 Global Hereditary Angioedema Drug Price by Application (2016-2021)
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Hereditary Angioedema Drug Market Status by Region
5.1 Global Hereditary Angioedema Drug Market by Region
5.1.1 Global Hereditary Angioedema Drug Sales Volume by Region
5.1.2 Global Hereditary Angioedema Drug Sales Value by Region
5.2 North America Hereditary Angioedema Drug Market Status
5.3 Europe Hereditary Angioedema Drug Market Status
5.4 Asia Pacific Hereditary Angioedema Drug Market Status
5.5 Central & South America Hereditary Angioedema Drug Market Status
5.6 Middle East & Africa Hereditary Angioedema Drug Market Status
6 North America Hereditary Angioedema Drug Market Status
6.1 North America Hereditary Angioedema Drug Market by Country
6.1.1 North America Hereditary Angioedema Drug Sales Volume by Country (2016-2021)
6.1.2 North America Hereditary Angioedema Drug Sales Value by Country (2016-2021)
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Hereditary Angioedema Drug Market Status
7.1 Europe Hereditary Angioedema Drug Market by Country
7.1.1 Europe Hereditary Angioedema Drug Sales Volume by Country (2016-2021)
7.1.2 Europe Hereditary Angioedema Drug Sales Value by Country (2016-2021)
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Hereditary Angioedema Drug Market Status
8.1 Asia Pacific Hereditary Angioedema Drug Market by Country
8.1.1 Asia Pacific Hereditary Angioedema Drug Sales Volume by Country (2016-2021)
8.1.2 Asia Pacific Hereditary Angioedema Drug Sales Value by Country (2016-2021)
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Hereditary Angioedema Drug Market Status
9.1 Central & South America Hereditary Angioedema Drug Market by Country
9.1.1 Central & South America Hereditary Angioedema Drug Sales Volume by Country (2016-2021)
9.1.2 Central & South America Hereditary Angioedema Drug Sales Value by Country (2016-2021)
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Hereditary Angioedema Drug Market Status
10.1 Middle East & Africa Hereditary Angioedema Drug Market by Country
10.1.1 Middle East & Africa Hereditary Angioedema Drug Sales Volume by Country (2016-2021)
10.1.2 Middle East & Africa Hereditary Angioedema Drug Sales Value by Country (2016-2021)
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
11.1 Supply Chain Analysis
11.2 Production Process Chart Analysis
11.3 Raw Materials and Key Suppliers Analysis
11.3.1 Raw Materials Introduction
11.3.2 Raw Materials Key Suppliers List
11.4 Hereditary Angioedema Drug Manufacturing Cost Analysis
11.5 Hereditary Angioedema Drug Sales Channel and Distributors Analysis
11.5.1 Hereditary Angioedema Drug Sales Channel
11.5.2 Hereditary Angioedema Drug Distributors
11.6 Hereditary Angioedema Drug Downstream Major Buyers
12 Global Hereditary Angioedema Drug Market Forecast by Type and by Application
12.1 Global Hereditary Angioedema Drug Sales Volume and Sales Value Forecast (2022-2027)
12.2 Global Hereditary Angioedema Drug Forecast by Type
12.2.1 Global Hereditary Angioedema Drug Sales Volume Forecast by Type
12.2.2 Global Hereditary Angioedema Drug Sales Value Forecast by Type
12.2.3 Global Hereditary Angioedema Drug Price Forecast by Type
12.3 Global Hereditary Angioedema Drug Forecast by Application
12.3.1 Global Hereditary Angioedema Drug Sales Volume Forecast by Application
12.3.2 Global Hereditary Angioedema Drug Sales Value Forecast by Application
12.3.3 Global Hereditary Angioedema Drug Price Forecast by Application
13 Global Hereditary Angioedema Drug Market Forecast by Region/Country
13.1 Global Hereditary Angioedema Drug Market Forecast by Region (2022-2027)
13.1.1 Global Hereditary Angioedema Drug Sales Volume Forecast by Region (2022-2027)
13.1.2 Global Hereditary Angioedema Drug Sales Value Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Takeda
14.1.1 Company Information
14.1.2 Hereditary Angioedema Drug Product Introduction
14.1.3 Takeda Hereditary Angioedema Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.1.4 SWOT Analysis
14.2 Pharming Group NV
14.2.1 Company Information
14.2.2 Hereditary Angioedema Drug Product Introduction
14.2.3 Pharming Group NV Hereditary Angioedema Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.2.4 SWOT Analysis
14.3 Ionis Pharmaceuticals, Inc.
14.3.1 Company Information
14.3.2 Hereditary Angioedema Drug Product Introduction
14.3.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.3.4 SWOT Analysis
14.4 IBio Inc.
14.4.1 Company Information
14.4.2 Hereditary Angioedema Drug Product Introduction
14.4.3 IBio Inc. Hereditary Angioedema Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.4.4 SWOT Analysis
14.5 CSL Limited
14.5.1 Company Information
14.5.2 Hereditary Angioedema Drug Product Introduction
14.5.3 CSL Limited Hereditary Angioedema Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.5.4 SWOT Analysis
14.6 BioCryst Pharmaceuticals, Inc.
14.6.1 Company Information
14.6.2 Hereditary Angioedema Drug Product Introduction
14.6.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.6.4 SWOT Analysis
...
15 Conclusion
16 Methodology

List of Figure

List of Tables

Table Global Hereditary Angioedema Drug Sales Value and CAGR by Region (2016-2027)
Table Global Hereditary Angioedema Drug Sales Volume by Company (2019-2021)
Table Global Hereditary Angioedema Drug Sales Volume Market Share by Company (2019-2021)
Table Global Hereditary Angioedema Drug Sales Value by Company (2019-2021)
Table Global Hereditary Angioedema Drug Sales Value and CAGR by Region (2016-2027)
Table Global Hereditary Angioedema Drug Price by Company (2019-2021)
Table Main Manufacturers Hereditary Angioedema Drug Product Location and Sales Area
Table Global Hereditary Angioedema Drug Sales Value by Company (2019-2021)
Table Global Hereditary Angioedema Drug Sales Volume by Type (2016-2021)
Table Global Hereditary Angioedema Drug Sales Volume Market Share by Type (2016-2021)
Table Global Hereditary Angioedema Drug Sales Value by Type (2016-2021)
Table Global Hereditary Angioedema Drug Sals Value Market Share by Type (2016-2021)
Table Global Hereditary Angioedema Drug Price by Type (2016-2021)
Table North America Hereditary Angioedema Drug Sales Volume by Type (2016-2021)
Table Global Hereditary Angioedema Drug Sales Value by Type (2016-2021)
Table Europe Hereditary Angioedema Drug Sales Volume by Type (2016-2021)
Table Europe Hereditary Angioedema Drug Sales Volume Market Share by Type (2016-2021)
Table Asia Pacific Hereditary Angioedema Drug Sales Volume by Type (2016-2021)
Table Asia Pacific Hereditary Angioedema Drug Sales Volume Market Share by Type (2016-2021)
Table Central & South America Hereditary Angioedema Drug Sales Volume by Type (2016-2021)
Table Central & South America Pacific Hereditary Angioedema Drug Sales Volume Market Share by Type (2016-2021)
Table Middle East & Africa Hereditary Angioedema Drug Sales Volume by Type (2016-2021)
Table Middle East & Africa Hereditary Angioedema Drug Sales Volume Market Share by Type (2016-2021)
Table Global Hereditary Angioedema Drug Sales Volume by Application (2016-2021)
Table Global Hereditary Angioedema Drug Sales Volume Market Share by Application (2016-2021)
Table Global Hereditary Angioedema Drug Sales Value by Application (2016-2021)
Table Global Hereditary Angioedema Drug Value Market Share by Application (2016-2021)
Table Global Hereditary Angioedema Drug Price by Application (2016-2021)
Table North America Hereditary Angioedema Drug Sales Volume by Application (2016-2021)
Table Global Hereditary Angioedema Drug Sales Value by Application (2016-2021)
Table Europe Hereditary Angioedema Drug Sales Volume by Application (2016-2021)
Table Europe Hereditary Angioedema Drug Sales Volume Market Share by Application (2016-2021)
Table Asia Pacific Hereditary Angioedema Drug Sales Volume by Application (2016-2021)
Table Asia Pacific Hereditary Angioedema Drug Sales Volume Market Share by Application (2016-2021)
Table Central & South America Hereditary Angioedema Drug Sales Volume by Application (2016-2021)
Table Central & South America Pacific Hereditary Angioedema Drug Sales Volume Market Share by Application (2016-2021)
Table Middle East & Africa Hereditary Angioedema Drug Sales Volume by Application (2016-2021)
Table Middle East & Africa Hereditary Angioedema Drug Sales Volume Market Share by Application (2016-2021)
Table Global Hereditary Angioedema Drug Sales Volume by Region (2016-2021)
Table Global Hereditary Angioedema Drug Sales Volume Market Share by Region (2016-2021)
Table Global Hereditary Angioedema Drug Sales Value by Region (2016-2021)
Table Global Hereditary Angioedema Drug Value Market Share by Region (2016-2021)
Table North America Hereditary Angioedema Drug Sales Volume by Country (2016-2021)
Table North America Hereditary Angioedema Drug Sales Volume Market Share by Country (2016-2021)
Table Global Hereditary Angioedema Drug Sales Value by Region/Country (2016-2021)
Table North America Hereditary Angioedema Drug Value Market Share by Country (2016-2021)
Table Europe Hereditary Angioedema Drug Sales Volume by Country (2016-2021)
Table Europe Hereditary Angioedema Drug Sales Volume Market Share by Country (2016-2021)
Table Europe Hereditary Angioedema Drug Sales Value by Country (2016-2021)
Table Europe Hereditary Angioedema Drug Value Market Share by Country (2016-2021)
Table Asia Pacific Hereditary Angioedema Drug Sales Volume by Country (2016-2021)
Table Asia Pacific Hereditary Angioedema Drug Sales Volume Market Share by Country (2016-2021)
Table Asia Pacific Hereditary Angioedema Drug Sales Value by Country (2016-2021)
Table Asia Pacific Hereditary Angioedema Drug Value Market Share by Country (2016-2021)
Table Central & South America Hereditary Angioedema Drug Sales Volume by Country (2016-2021)
Table Central & South America Hereditary Angioedema Drug Sales Volume Market Share by Country (2016-2021)
Table Central & South America Hereditary Angioedema Drug Sales Value by Country (2016-2021)
Table Central & South America Hereditary Angioedema Drug Value Market Share by Country (2016-2021)
Table Middle East & Africa Hereditary Angioedema Drug Sales Volume by Country (2016-2021)
Table Middle East & Africa Hereditary Angioedema Drug Sales Volume Market Share by Country (2016-2021)
Table Middle East & Africa Hereditary Angioedema Drug Sales Value by Country (2016-2021)
Table Middle East & Africa Hereditary Angioedema Drug Value Market Share by Country (2016-2021)
Table Hereditary Angioedema Drug Raw Materials Key Suppliers List
Table Hereditary Angioedema Drug Distributors List
Table Hereditary Angioedema Drug Buyers List
Table Global Hereditary Angioedema Drug Sales Volume Forecast by Type (2022-2027)
Table Global Hereditary Angioedema Drug Sales Volume Market Share Forecast by Type (2022-2027)
Table Global Hereditary Angioedema Drug Value Forecast by Type (2022-2027)
Table Global Hereditary Angioedema Drug Value Market Share Forecast by Type (2022-2027)
Table Global Hereditary Angioedema Drug Price Forecast by Type (2022-2027)
Table Global Hereditary Angioedema Drug Sales Volume Forecast by Application (2022-2027)
Table Global Hereditary Angioedema Drug Value Forecast by Type (2022-2027)
Table Global Hereditary Angioedema Drug Value Forecast by Application (2022-2027)
Table Global Hereditary Angioedema Drug Value Market Share Forecast by Application (2022-2027)
Table Global Hereditary Angioedema Drug Price Forecast by Application (2022-2027)
Table Global Hereditary Angioedema Drug Sales Volume Forecast by Region (2022-2027)
Table Global Hereditary Angioedema Drug Value Forecast by Application (2022-2027)
Table Global Hereditary Angioedema Drug Value Forecast by Region (2022-2027)
Table Global Hereditary Angioedema Drug Value Market Share Forecast by Region (2022-2027)
Table Takeda Company Information
Table Takeda Product Introduction
Table Global Hereditary Angioedema Drug Value Forecast by Region (2022-2027)
Table Pharming Group NV Company Information
Table Pharming Group NV Product Introduction
Table Pharming Group NV Hereditary Angioedema Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Ionis Pharmaceuticals, Inc. Company Information
Table Ionis Pharmaceuticals, Inc. Product Introduction
Table Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table IBio Inc. Company Information
Table IBio Inc. Product Introduction
Table IBio Inc. Hereditary Angioedema Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table CSL Limited Company Information
Table CSL Limited Product Introduction
Table CSL Limited Hereditary Angioedema Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table BioCryst Pharmaceuticals, Inc. Company Information
Table BioCryst Pharmaceuticals, Inc. Product Introduction
Table BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)